http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103509011-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
filingDate | 2012-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103509011-B |
titleOfInvention | 1-(4-hydroxyl-3-formamido group acidic group-phenyl)-β-carboline, preparation, anti-inflammatory and anti-tumor activity and application |
abstract | [in formula, R is H or CH to the invention discloses 17 kinds of compounds of general formula In 2 cn 6 hn 5 when R is H, AA is selected from L-Ala, L-Ile, L-Phe, L-Asp (OBzl), L-Leu, L-Val, L-Tyr, L-Glu (OBzl), L-Arg (NOn 2 ), L-Trp, L-Met, L-Thr, L-Lys (Z), L-Ser (Me), L-Gly residue; When R is CHn 2 cn 6 hn 5 time AA-OBzl be OBzl jointly], disclose their preparation method, also disclose their anti-inflammatory activity and anti-tumor activity.Thus 17 kinds of compounds of general formula I have anti-inflammatory and antitumor dual function, can be used as tumor prevention and therapeutical agent use. |
priorityDate | 2012-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.